|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| 1. Cash Flows from Operating Activities | |||||
| Consolidated Net Income for the Fiscal Year | |||||
| Profit Adjustments | |||||
| Depreciation of Tangible Assets | |||||
| Amortization of Intangible Assets | |||||
| Impairment Losses on Other Assets (Net) | |||||
| Provisions (Net) | |||||
| Impairment losses on financial assets (net) | |||||
| Net gains on disposal of permanent assets, investments, and non-current assets held for sale | |||||
| Income (Loss) Share under the Equity Method | |||||
| Deferred Taxes | |||||
| Judicial Deposits Adjustment | |||||
| Recoverable Taxes Adjustment | |||||
| Effects of Exchange Rate Fluctuations on Assets and Liabilities | |||||
| Other | |||||
| Net (Increase) Decrease in Operating Assets | |||||
| Financial Assets Measured at Fair Value through Profit or Loss | |||||
| Financial Assets Measured at Fair Value Through Other Comprehensive Income | |||||
| Financial Assets Measured at Amortized Cost | |||||
| Other Assets | |||||
| Net Increase (Decrease) in Operating Liabilities | |||||
| Financial Liabilities Measured at Fair Value Through Profit or Loss | |||||
| Financial Liabilities Measured at Amortized Cost | |||||
| Other Liabilities | |||||
| Tax Paid | |||||
| Total Net Cash Flow from Operating Activities (1) | |||||
| 2. Cash Flows From Investing Activities | |||||
| Investments | |||||
| Increase in Subsidiaries | |||||
| Tangible Assets | |||||
| Intangible Assets | |||||
| Non-current Assets Held for Sale | |||||
| Disposal | |||||
| Dividends and Interest on Equity Received | |||||
| Dividends / Interest on Equity Received from Investments in Associates and Jointly Controlled Entities | |||||
| Total Net Cash Flow from Investing Activities (2) | |||||
| 3. Cash Flows from Financing Activities | |||||
| Acquisition of own shares | |||||
| Acquisition (Disposal) of Own Shares | |||||
| Issuance (Repurchase) of Debt Instruments Eligible as Capital | |||||
| Issuance of Other Long-term Financial Liabilities | |||||
| Dividends and Interest on Equity Paid | |||||
| Payments of Other Long-term Financial Liabilities | |||||
| Interest Payments on Debt Instruments Eligible as Capital | |||||
| Increase (Decrease) in Non-controlling Interests | |||||
| Total Net Cash Flow from Financing Activities (3) | |||||
| Net Increase (Decrease) in Cash and Cash Equivalents (1+2+3) | |||||
| Cash and Cash Equivalents at the Beginning of the Fiscal Year | |||||
| Cash and Cash Equivalents at the End of the Fiscal Year | |||||
Loading...